Back

GDF-15 and the effect of empagliflozin in heart failure: findings from the EMPEROR Program

20 May 2023 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: Acute heart failure - diagnostic methods Biomarkers HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Joao Pedro Ferreira

University of Porto, Porto (Portugal)

6 More presentations in this session

Presentation thumbnail
Predictors of spot urinary sodium in patients with acute decompensated heart failure: a sub analysis of the TAILOR-AHF randomized trial
Miss D. Hofman (Heerlen, NL)
Abstract Slides
Presentation thumbnail
Cardiac troponin t (cTnT) and n-terminal pro-B-type natriuretic peptides (NT-proBNP) for prediction of 30-day readmission or death in patients with acute dyspnea: data from the ACE2 study
Doctor R. Bhatnagar (Oslo, NO)
Abstract Slides
Presentation thumbnail
Predictive value of urinary spot sodium in acutely decompensated heart failure: results from the TAILOR-AHF observational study
Doctor M. Hoen (Heerlen, NL)
Abstract Slides
Presentation thumbnail
Predictive value of NT-proBNP in patients hospitalized for acute heart failure
Doctor A. Milovancev (Novi Sad, RS)
Abstract Slides
Presentation thumbnail
The source of liberation of dipeptidyl peptidase 3 (DPP3), a newly emerged cardiac biomarker, in pathological situations
Miss N. Assad (Paris, FR)
Abstract Slides

Access the full session

Session thumbnail
Acute heart failure - diagnostic methods

The Event

Event poster

Heart Failure 2023

20 May 2023 10:00 CET
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on current state of the diagnosis of heart failure
thumbnail
Congress Presentation
The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure
thumbnail
Congress Session
From genetic signatures to clinical implications

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources